These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Stimulant-atypical antipsychotic interaction and acute dystonia. Benjamin E; Salek S J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):510-2. PubMed ID: 15908830 [No Abstract] [Full Text] [Related]
25. [Tourette syndrome: an analysis of its comorbidity and specific treatment]. Castellanos FX; Acosta MT Rev Neurol; 2004 Feb; 38 Suppl 1():S124-30. PubMed ID: 15011166 [TBL] [Abstract][Full Text] [Related]
26. Current and Investigational Medication Delivery Systems for Treating Attention-Deficit/Hyperactivity Disorder. Jain R; Katic A Prim Care Companion CNS Disord; 2016 Aug; 18(4):. PubMed ID: 27828696 [TBL] [Abstract][Full Text] [Related]
28. Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association. Rippel CA; Kobets AJ; Yoon DY; Williams PN; Shugart YY; Bridges DD; Vandenbergh DJ; Singer HS Psychiatr Genet; 2006 Oct; 16(5):179-80. PubMed ID: 16969268 [TBL] [Abstract][Full Text] [Related]
29. Do stimulants provoke, cause, or exacerbate tics and Tourette syndrome? Shapiro AK; Shapiro E Compr Psychiatry; 1981; 22(3):265-73. PubMed ID: 6113096 [No Abstract] [Full Text] [Related]
30. The use of imipramine in Tourette's syndrome and attention deficit disorder: case report. Dillon DC; Salzman IJ; Schulsinger DA J Clin Psychiatry; 1985 Aug; 46(8):348-9. PubMed ID: 2862138 [TBL] [Abstract][Full Text] [Related]
32. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. Castellanos FX; Giedd JN; Elia J; Marsh WL; Ritchie GF; Hamburger SD; Rapoport JL J Am Acad Child Adolesc Psychiatry; 1997 May; 36(5):589-96. PubMed ID: 9136492 [TBL] [Abstract][Full Text] [Related]
33. Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine. Linet LS J Clin Psychiatry; 1987 Nov; 48(11):456. PubMed ID: 3479424 [No Abstract] [Full Text] [Related]
34. Pharmacotherapeutic challenges in treatment of a child with "the triad" of obsessive compulsive disorder, attention-deficit/hyperactivity disorder and Tourette's disorder. Rice T; Coffey B J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):176-9. PubMed ID: 25782100 [No Abstract] [Full Text] [Related]
36. Dopamine transporter genotype influences the physiological response to medication in ADHD. Gilbert DL; Wang Z; Sallee FR; Ridel KR; Merhar S; Zhang J; Lipps TD; White C; Badreldin N; Wassermann EM Brain; 2006 Aug; 129(Pt 8):2038-46. PubMed ID: 16760197 [TBL] [Abstract][Full Text] [Related]
37. What's all the fuss about Ritalin? Accardo P; Blondis TA J Pediatr; 2001 Jan; 138(1):6-9. PubMed ID: 11148505 [No Abstract] [Full Text] [Related]
38. Tourette's syndrome and attention deficit disorder with hyperactivity. Comings DE; Comings BG Arch Gen Psychiatry; 1987 Nov; 44(11):1023-6. PubMed ID: 3479057 [No Abstract] [Full Text] [Related]
39. Families of patients with attention-deficit hyperactivity disorder. Jerome L Can J Psychiatry; 1997 Mar; 42(2):211. PubMed ID: 9067073 [No Abstract] [Full Text] [Related]
40. Gilles de la Tourette's syndrome: tics and central nervous system stimulants in twins and nontwins. Price RA; Leckman JF; Pauls DL; Cohen DJ; Kidd KK Neurology; 1986 Feb; 36(2):232-7. PubMed ID: 2868428 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]